Global Drug Trends

Transparency Expands Fentanyl Test Strip Distribution Across California Under New $2M DHCS Contract

Transparency, the infrastructure organization behind Bunk Police and DanceSafe, has been selected as the operational partner on a two-year, $2 million California Department of Health Care Services contract to expand fentanyl test strip access statewide. Transparency is handling production, supply chain, and fulfillment, the operational...

Medetomidine and a New Wave of Deadly Adulterants

The drug supply is evolving again. Just when public health agencies and harm reductionists were starting to wrap their heads around xylazine and nitazene, a new veterinary sedative has entered the scene: medetomidine. It's stronger, less predictable, and even more dangerous. What Is Medetomidine, and Why Is It in the Fentanyl Supply? Medetomidine is a...

Psilocybin Paradox: The Military Cracks Down on Psilocin Testing While Veterans Explore Psychedelic Therapy

Pentagon Adds Psilocin to the Drug Testing Panel Starting October 1, 2025, the Department of Defense will begin military psilocin testing as part of its expanded Drug Demand Reduction Program. A recent memo confirms that service members’ samples will now be screened for psilocin, the metabolite of psilocybin mushrooms. Officials argue that psychedelic use poses risks...

Germany’s Psilocybin Compassionate‑Use Program: Europe’s First for Treatment‑Resistant Depression

Germany has taken a historic step by permitting psychiatrists to prescribe psilocybin for treatment‑resistant depression under a compassionate‑use framework. This marks the first time a European Union country has given doctors authority to administer the psychedelic compound outside of clinical trials. The Central Institute of Mental Health (CIMH) in Mannheim and Berlin’s OVID Clinic, both...